- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adverum Biotechnologies Inc (ADVM)
NASDAQ
Symbol | Exchange | Currency |
|---|
1.470
0.000(0.00%)
- Volume:103,163
- Day's Range:1.431 - 1.500
- 52 wk Range:0.795 - 2.565
ADVM Overview
- Prev. Close
- 1.47
- Day's Range
- 1.431-1.5
- Revenue
- -
- Open
- 1.5
- 52 wk Range
- 0.795-2.565
- EPS
- -1.57
- Volume
- 103,163
- Market Cap
- 145.03M
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 1,322,619
- P/E Ratio
- -
- Beta
- -
- 1-Year Change
- -37.18%
- Shares Outstanding
- 99,333,578
- Next Earnings Date
- Nov 10, 2022
What is your sentiment on Adverum Biotechn?
or
Vote to see community's results!
Adverum Biotechnologies Inc News
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.71%
- ByInvesting.com-
Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Telecoms, Financials and Oil & Gas sectors led shares higher. At the close in NYSE, the Dow...
- Orbimed Advisors reduced stake in Graybug Vision, Inc.
- ByInvesting.com-
On the 25th of March, Orbimed Advisors sold 313 thousand Graybug Vision, Inc. (GRAY) shares for $1.9 million at an average price of $6.16 per share. Shares of Graybug Vision, Inc....
Adverum Biotechnologies Inc Analysis
- Stock Charts To Watch: CARS, DQ, LPSN, OSTK, SE, SPCE
1. Cars.com (CARS) Cars.com (NYSE:CARS) broke out of a base on Wednesday. It came down from 14 to 3, and change, formed a nice base, popped, failed to go to the 50-day, backed...
- 6 Stock Charts to Watch: ADVM, AKBA, APLT, CLSK, OBSV, TGTX
1. Adverum Biotechnologies (ADVM)ADVM made a powerful move on Tuesday, above a double-top and breakaway gap, and jumped 5.27, or 38%, to 19.00, after reaching a multi-week and...
- Adverum (ADVM): Strong Industry, Solid Earnings Estimate Revisions
One stock that might be an intriguing choice for investors right now is Adverum Biotechnologies, Inc. (NASDAQ:ADVM) . This is because this security in the Medical - Biomedical and...
Adverum Biotechnologies Inc Company Profile
Adverum Biotechnologies Inc Company Profile
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company, which targets unmet medical needs in ocular and rare diseases. The Company develops gene therapy product candidates. Its lead product candidate, ADVM-022, is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. ADVM-022 is being developed for the treatment of patients with wet age-related macular degeneration (wet AMD) who are responsive to anti-VEGF therapy. The Company's second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy (BCM) via a single IVT injection.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Strong Sell | Sell | Sell |
| Technical Indicators | Buy | Buy | Strong Sell | Sell | Strong Sell |
| Summary | Neutral | Neutral | Strong Sell | Sell | Strong Sell |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 265.03 | 265.59 | 261.26 | +2.85 | +1.09% | 915.36K | NYSE | |||
| 8.10 | 8.12 | 7.85 | -0.26 | -3.16% | 3.34M | NYSE | |||
| 100.81 | 101.85 | 99.80 | -0.02 | -0.02% | 35.92M | NASDAQ | |||
| 31.64 | 31.65 | 30.71 | -1.11 | -3.39% | 3.91M | NYSE | |||
| 176.09 | 179.33 | 171.85 | +4.91 | +2.87% | 3.18M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 1.16 | 1.19 | 1.15 | -0.0500 | -4.13% | 1.63M | NYSE | |||
| 166.08 | 166.41 | 165.13 | +0.78 | +0.47% | 3.79M | NYSE | |||
| 45.35 | 45.49 | 44.78 | -0.91 | -1.97% | 1.07M | NYSE | |||
| 3.525 | 3.55 | 3.47 | -0.075 | -2.08% | 7.04M | NYSE | |||
| 1.07 | 1.09 | 1.05 | -0.0300 | -2.73% | 74.36K | NYSE | |||
| 49.68 | 50.06 | 49.40 | -0.43 | -0.86% | 5.94M | NYSE | |||
| 134.78 | 134.81 | 132.25 | +0.77 | +0.57% | 1.27M | NYSE | |||
| 7.28 | 7.31 | 6.73 | +0.410 | +5.97% | 3.10M | NYSE | |||
| 39.37 | 40.38 | 38.81 | -1.37 | -3.36% | 2.84M | NYSE |
- Feb 23, 2022, 24:53thsi stock goign all way doen to 0...... Get out before its to late
- Jan 13, 2022, 19:36what's going on?
- Oct 18, 2021, 23:54buy...?
- Jun 07, 2021, 23:22long term investment
- May 07, 2021, 19:27great bargain buy right now
- May 07, 2021, 19:26great bargain!!
- Apr 30, 2021, 15:40this is not a stocks
- Apr 30, 2021, 18:47Why ?
- Apr 30, 2021, 03:01good oportunity to.buy
- Apr 29, 2021, 23:38Short it
- Apr 30, 2021, 24:07Too late
- Apr 30, 2021, 24:26very late
- Apr 29, 2021, 23:23what is going with it